Search Results 1501-1510 of 13230 for transexamic

  1. Publications - Mark H. Winemiller, M.D. - Mayo Clinic

    Johnson SE, Winemiller MH. Pathologic Hip Fracture Demonstrated on Ultrasound. PM R 2020 Feb; 12 (2):219-220 Epub 2019 Sept 06

  2. A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

    The primary objective of this study is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal ...

  3. Self-management of Sedative Therapy by Ventilated Patients - Mayo Clinic

    The purpose of this randomized clinical trial is to test the efficacy of dexmedetomidine for the self-management of sedative therapy (SMST) in a sample of ...

  4. Exagamglogene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

    Exagamglogene autotemcel injection is used to treat sickle cell disease (red blood cell disease) in patients who have frequent vaso-occlusive crisis. It is also ...

  5. Tongue-tie (ankyloglossia) - Doctors and departments - Mayo Clinic

    In this condition present at birth, a band of tissue (lingual frenulum) tethers the tongue to the floor of the mouth, restricting the range of motion.

  6. Publications - Raheel Shafay, M.B.B.S., M.D. - Mayo Clinic

    Labadie JG, Hashim R, Raheel S, Awad L, Jain M. A 2018 Approach to Combating Methotrexate Toxicity Folic Acid and Beyond. Bull Hosp Jt Dis (2013).

  7. Coagulation factor ix recombinant, glycopegylated (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is to be given only by or under the supervision of your doctor or other health care professional. This product is available in the following ...

  8. FDA-approved drug to prevent migraine shows promise after Mayo Clinic-involved study

    The FDA approved erenumab (Aimovig) for migraine prevention after three randomized, controlled trials showed an overall 50 percent reduction in the frequency of ...

  9. Publications - Leigh G. Griffiths, Ph.D., MRCVS - Mayo Clinic

    Wu J, Deng J, Theocharidis G, Sarrafian TL, Griffiths LG, Bronson RT, Veves A, Chen J, Yuk H, Zhao X. Author Correction: Adhesive anti-fibrotic interfaces ...

  10. Mayo researchers say oral apixaban safe and effective for treating blood clots in cancer patients

    SAN DIEGO — Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and ...